Reverse Potts shunt in severe pulmonary hypertension: A 20-year retrospective review

Wei Jiang1, Zhongshi Wu1, Can Huang1

  • 1Department of Cardiovascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.

Insights

Reverse Potts shunt (RPS) offers a promising treatment for pediatric pulmonary arterial hypertension (PAH), improving cardiac function and survival. Further research is needed to optimize patient selection and technique for this innovative therapy.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Surgical Interventions

Background:

  • Pulmonary arterial hypertension (PAH) in children leads to right heart failure, with unsatisfactory outcomes despite advances.
  • PAH-specific therapies have improved management, but prognosis remains a concern for many pediatric patients.

Purpose of the Study:

  • To review the clinical experience and efficacy of reverse Potts shunt (RPS) in treating pediatric pulmonary arterial hypertension (PAH).
  • To discuss challenges and guide clinical practice for RPS in PAH management.

Main Methods:

  • Retrospective summary of accumulated clinical experience with RPS over the past 20 years.
  • Analysis of RPS application in pediatric PAH patients.

Main Results:

  • RPS effectively improves cardiac function and survival time in PAH patients.
  • Midterm survival rates with RPS are comparable to lung transplantation.
  • RPS alleviates right heart burden by creating a shunt between the pulmonary artery and descending aorta.

Conclusions:

  • RPS is a valuable palliative option for pediatric PAH, offering improved outcomes.
  • Challenges include identifying suitable patients, optimal timing, and shunt selection.
  • Further refinement of RPS techniques and patient selection criteria is crucial for broader clinical application.

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...